Sponsor pipeline

Bleeding and Clotting Disorders Institute Peoria, Illinois clinical trial pipeline

Get alerts when Bleeding and Clotting Disorders Institute Peoria, Illinois's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 1
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1
NCT05500807 Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A Von Willebrand Disease, Type 3 Recruiting 2026-04-03

Disease areas by active trials

Hemophilia (1)

Get alerts when Bleeding and Clotting Disorders Institute Peoria, Illinois's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free